Literature DB >> 27251920

ST elevation myocardial infarction.

Tawfiq Choudhury1, Nick Ej West2, Magdi El-Omar1.   

Abstract

ST segment elevation myocardial infarction remains a significant contributor to morbidity and mortality worldwide, despite a declining incidence and better survival rates. It usually results from thrombotic occlusion of a coronary artery at the site of a ruptured or eroded plaque. Diagnosis is based on characteristic symptoms and electrocardiogram changes, and confirmed subsequently by raised cardiac enzymes. Prognosis is dependent on the size of the infarct, presence of collaterals and speed with which the occluded artery is reopened. Mechanical reperfusion by primary percutaneous coronary intervention is superior to fibrinolytic therapy if delivered by an experienced team in a timely fashion. Post-reperfusion care includes monitoring for complications, evaluation of left ventricular function, secondary preventive therapy and cardiac rehabilitation.
© 2016 Royal College of Physicians.

Entities:  

Keywords:  ST elevation myocardial infarction; fibrinolysis; primary percutaneous coronary intervention

Mesh:

Year:  2016        PMID: 27251920      PMCID: PMC5922709          DOI: 10.7861/clinmedicine.16-3-277

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  39 in total

1.  Thrombus aspiration during primary percutaneous coronary intervention.

Authors:  Tone Svilaas; Pieter J Vlaar; Iwan C van der Horst; Gilles F H Diercks; Bart J G L de Smet; Ad F M van den Heuvel; Rutger L Anthonio; Gillian A Jessurun; Eng-Shiong Tan; Albert J H Suurmeijer; Felix Zijlstra
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245

2.  Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.

Authors:  Shamir R Mehta; Jean-Francois Tanguay; John W Eikelboom; Sanjit S Jolly; Campbell D Joyner; Christopher B Granger; David P Faxon; Hans-Jurgen Rupprecht; Andrzej Budaj; Alvaro Avezum; Petr Widimsky; Philippe Gabriel Steg; Jean-Pierre Bassand; Gilles Montalescot; Carlos Macaya; Giuseppe Di Pasquale; Kari Niemela; Andrew E Ajani; Harvey D White; Susan Chrolavicius; Peggy Gao; Keith A A Fox; Salim Yusuf
Journal:  Lancet       Date:  2010-10-09       Impact factor: 79.321

3.  Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective.

Authors:  Robert J Goldberg; Frederick A Spencer; Joel M Gore; Darleen Lessard; Jorge Yarzebski
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

4.  Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.

Authors:  Marc S Sabatine; Christopher P Cannon; C Michael Gibson; Jose L López-Sendón; Gilles Montalescot; Pierre Theroux; Marc J Claeys; Frank Cools; Karen A Hill; Allan M Skene; Carolyn H McCabe; Eugene Braunwald
Journal:  N Engl J Med       Date:  2005-03-09       Impact factor: 91.245

5.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Authors:  Lars Wallentin; Richard C Becker; Andrzej Budaj; Christopher P Cannon; Håkan Emanuelsson; Claes Held; Jay Horrow; Steen Husted; Stefan James; Hugo Katus; Kenneth W Mahaffey; Benjamin M Scirica; Allan Skene; Philippe Gabriel Steg; Robert F Storey; Robert A Harrington; Anneli Freij; Mona Thorsén
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

6.  Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.

Authors:  D W Muller; E J Topol; S G Ellis; K N Sigmon; K Lee; R M Califf
Journal:  Am Heart J       Date:  1991-04       Impact factor: 4.749

7.  Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts.

Authors:  Giuseppe De Luca; Harry Suryapranata; Jan Paul Ottervanger; Elliott M Antman
Journal:  Circulation       Date:  2004-03-08       Impact factor: 29.690

8.  Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study.

Authors:  Pieter J Vlaar; Tone Svilaas; Iwan C van der Horst; Gilles F H Diercks; Marieke L Fokkema; Bart J G L de Smet; Ad F M van den Heuvel; Rutger L Anthonio; Gillian A Jessurun; Eng-Shiong Tan; Albert J H Suurmeijer; Felix Zijlstra
Journal:  Lancet       Date:  2008-06-07       Impact factor: 79.321

Review 9.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

10.  Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.

Authors:  Gilles Montalescot; Stephen D Wiviott; Eugene Braunwald; Sabina A Murphy; C Michael Gibson; Carolyn H McCabe; Elliott M Antman
Journal:  Lancet       Date:  2009-02-28       Impact factor: 79.321

View more
  13 in total

1.  Using real world evidence to generate cost-effectiveness analysis of fibrinolytic therapy in patients with ST-segment elevation myocardial infarction in Thailand.

Authors:  Krittimeth Trerayapiwat; Peerawat Jinatongthai; Prin Vathesatogkit; Piyamitr Sritara; Ninutcha Paengsai; Piyameth Dilokthornsakul; Surakit Nathisuwan; Lan My Le; Nathorn Chaiyakunapruk
Journal:  Lancet Reg Health West Pac       Date:  2022-06-24

2.  Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction.

Authors:  Mustafa Yolcu; Fusun Gunesdogdu; Metin Bektas; Derya Turan Bayirli; Kivanc Serefhanoglu
Journal:  Cardiovasc J Afr       Date:  2020-05-05       Impact factor: 1.167

3.  The Importance of the 15-lead Versus 12-lead ECG Recordings in the Diagnosis and Treatment of Right Ventricle and Left Ventricle Posterior and Lateral Wall Acute Myocardial Infarctions.

Authors:  Ioannis Vogiatzis; Efstathios Koulouris; Antonios Ioannidis; Evangelos Sdogkos; Maria Pliatsika; Pavlos Roditis; Markos Goumenakis
Journal:  Acta Inform Med       Date:  2019-03

4.  A retrospective study of an invasive versus conservative strategy in patients aged ≥80 years with acute ST-segment elevation myocardial infarction.

Authors:  Yong-Gang Sui; Si-Yong Teng; Jie Qian; Yuan Wu; Ke-Fei Dou; Yi-Da Tang; Shu-Bin Qiao; Yong-Jian Wu
Journal:  J Int Med Res       Date:  2019-07-26       Impact factor: 1.671

5.  Case Report: Abnormal ECG in a Patient With Acute Pancreatitis.

Authors:  Yunxiang Long; Manyun Tang; Jie Wang; Hui Liu; Zhijie Jian; Guoliang Li; Chang Liu
Journal:  Front Cardiovasc Med       Date:  2021-12-23

6.  Comparison of Efficacy and Safety of Recombinant Human Prourokinase and Alteplase in the Treatment of STEMI and Analysis of Influencing Factors of Efficacy.

Authors:  Yizhou Liu; Yulin Yang; Ying Li; Xiaoqing Peng
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-06       Impact factor: 2.629

7.  Comparison of the Characteristics, Management, and Outcomes of STEMI Patients Presenting With vs. Those of Patients Presenting Without COVID-19 Infection: A Systematic Review and Meta-Analysis.

Authors:  Yanjiao Wang; Linlin Kang; Ching-Wen Chien; Jiawen Xu; Peng You; Sizhong Xing; Tao-Hsin Tung
Journal:  Front Cardiovasc Med       Date:  2022-03-14

Review 8.  Deep Learning for Detecting and Locating Myocardial Infarction by Electrocardiogram: A Literature Review.

Authors:  Ping Xiong; Simon Ming-Yuen Lee; Ging Chan
Journal:  Front Cardiovasc Med       Date:  2022-03-25

9.  Ischemic postconditioning protects nonculprit coronary arteries against ischemia-reperfusion injury via downregulating miR-92a, miR-328 and miR-494.

Authors:  Jian Wang; Wu Wang; Chengying Yan; Tianzhen Wang
Journal:  Aging (Albany NY)       Date:  2022-03-23       Impact factor: 5.682

10.  Improved Cardiac Function and Attenuated Inflammatory Response by Additional Administration of Tirofiban during PCI for ST-Segment Elevation Myocardial Infarction Patients.

Authors:  Jing Zhang; Guomin Ding
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-16       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.